Jazz Pharmaceuticals Statistics
Total Valuation
JAZZ has a market cap or net worth of $16.27 billion. The enterprise value is $18.48 billion.
| Market Cap | 16.27B |
| Enterprise Value | 18.48B |
Important Dates
The last earnings date was Monday, August 3, 2026, after market close.
| Earnings Date | Aug 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
JAZZ has 64.91 million shares outstanding. The number of shares has increased by 5.40% in one year.
| Current Share Class | 64.91M |
| Shares Outstanding | 64.91M |
| Shares Change (YoY) | +5.40% |
| Shares Change (QoQ) | +4.99% |
| Owned by Insiders (%) | 2.97% |
| Owned by Institutions (%) | 100.00% |
| Float | 62.94M |
Valuation Ratios
The trailing PE ratio is 17.13 and the forward PE ratio is 9.93. JAZZ's PEG ratio is 0.18.
| PE Ratio | 17.13 |
| Forward PE | 9.93 |
| PS Ratio | 3.54 |
| Forward PS | 3.35 |
| PB Ratio | 3.38 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 10.23 |
| P/OCF Ratio | 9.80 |
| PEG Ratio | 0.18 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.59, with an EV/FCF ratio of 11.61.
| EV / Earnings | 19.65 |
| EV / Sales | 4.02 |
| EV / EBITDA | 9.59 |
| EV / EBIT | 15.29 |
| EV / FCF | 11.61 |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.92.
| Current Ratio | 1.78 |
| Quick Ratio | 1.38 |
| Debt / Equity | 0.92 |
| Debt / EBITDA | 2.25 |
| Debt / FCF | 2.77 |
| Interest Coverage | 4.67 |
Financial Efficiency
Return on equity (ROE) is 22.11% and return on invested capital (ROIC) is 17.17%.
| Return on Equity (ROE) | 22.11% |
| Return on Assets (ROA) | 6.86% |
| Return on Invested Capital (ROIC) | 17.17% |
| Return on Capital Employed (ROCE) | 13.66% |
| Weighted Average Cost of Capital (WACC) | 5.91% |
| Revenue Per Employee | $1.59M |
| Profits Per Employee | $325,520 |
| Employee Count | 2,890 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 0.84 |
Taxes
| Income Tax | -213.24M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +96.23% in the last 52 weeks. The beta is 0.36, so JAZZ's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | +96.23% |
| 50-Day Moving Average | 247.45 |
| 200-Day Moving Average | 203.54 |
| Relative Strength Index (RSI) | 50.19 |
| Average Volume (20 Days) | 1,105,610 |
Short Selling Information
The latest short interest is 3.61 million, so 5.57% of the outstanding shares have been sold short.
| Short Interest | 3.61M |
| Short Previous Month | 3.36M |
| Short % of Shares Out | 5.57% |
| Short % of Float | 5.74% |
| Short Ratio (days to cover) | 4.66 |
Income Statement
In the last 12 months, JAZZ had revenue of $4.60 billion and earned $940.75 million in profits. Earnings per share was $14.63.
| Revenue | 4.60B |
| Gross Profit | 4.20B |
| Operating Income | 1.21B |
| Pretax Income | 727.51M |
| Net Income | 940.75M |
| EBITDA | 1.93B |
| EBIT | 1.21B |
| Earnings Per Share (EPS) | $14.63 |
Balance Sheet
The company has $2.20 billion in cash and $4.41 billion in debt, with a net cash position of -$2.21 billion or -$34.04 per share.
| Cash & Cash Equivalents | 2.20B |
| Total Debt | 4.41B |
| Net Cash | -2.21B |
| Net Cash Per Share | -$34.04 |
| Equity (Book Value) | 4.80B |
| Book Value Per Share | 74.10 |
| Working Capital | 1.74B |
Cash Flow
In the last 12 months, operating cash flow was $1.66 billion and capital expenditures -$69.75 million, giving a free cash flow of $1.59 billion.
| Operating Cash Flow | 1.66B |
| Capital Expenditures | -69.75M |
| Depreciation & Amortization | 718.00M |
| Net Borrowing | -1.03B |
| Free Cash Flow | 1.59B |
| FCF Per Share | $24.51 |
Margins
Gross margin is 91.35%, with operating and profit margins of 26.28% and 20.45%.
| Gross Margin | 91.35% |
| Operating Margin | 26.28% |
| Pretax Margin | 15.81% |
| Profit Margin | 20.45% |
| EBITDA Margin | 41.88% |
| EBIT Margin | 26.28% |
| FCF Margin | 34.58% |
Dividends & Yields
JAZZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.40% |
| Shareholder Yield | -5.40% |
| Earnings Yield | 5.78% |
| FCF Yield | 9.78% |
Analyst Forecast
The average price target for JAZZ is $286.90, which is 14.45% higher than the current price. The consensus rating is "Buy".
| Price Target | $286.90 |
| Price Target Difference | 14.45% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (3Y) | 8.66% |
| EPS Growth Forecast (3Y) | 52.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
JAZZ has an Altman Z-Score of 2.08 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.08 |
| Piotroski F-Score | 7 |